Moreover, new onset af (noaf) is a frequent finding after transcatheter aortic valve replacement (tavr) There is lack of clear evidence about the optimal management of. Additionally, these patients were at a 37 percent higher risk of death one year after the tavr procedure as well. Transcatheter aortic valve replacement (tavr) has transformed the management of patients with severe symptomatic aortic stenosis who are unfit for surgical aortic valve replacement Atrial fibrillation is one of the most common arrhythmias observed in patients with aortic stenosis undergoing tavr Our study explores the impact of afib on perioperative outcomes in patients undergoing tavr.
Learn important facts about atrial fibrillation after heart surgery from dr Marc gillinov, the chair of cardiac surgery at the cleveland clinic. Patients with atrial fibrillation undergoing transcatheter aortic valve replacement are at an increased risk of death and other adverse outcomes when compared with patients in normal sinus rhythm having the procedure, according to a new analysis Transcatheter aortic valve replacement (tavr) is increasingly used in patients with aortic stenosis However, the optimal postoperative anticoagulation therapy for patients with atrial fibrillation (af) remains controversial We aimed to investigate the association between anticoagulant therapy selection and outcomes in patients with af after tavr.
Some of these patients have preexisting af as well The management of these patients is complex, especially after the procedure, when there is a sudden change in hemodynamics There are no established guidelines about the management of the patients who underwent transcatheter.
WATCH
